drugset / Trial / NCT02269800

An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD

NCT02269800

Phase 4 Unknown 60 enrolled Lustre Pharmaceutical Lab Co., Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of study is to evaluate the efficacy and safety of Benzalkonium Chloride Solution clearing the oral colonized bacterium in hospitalized patients with COPD.

Timeline

Start
2014-10
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject BENZALKONIUM Small molecule